Clinical trial
Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation…
NCT00003081 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003081 |
|---|---|
| Title | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma |
| Official title | A Phase I Trial of Busulfan, Thiotepa and Melphalan Followed by Autologous or Syngeneic Peripheral Blood Stem Cell Transplantation and Followed by Total Marrow (Skeletal) Irradiation (TMI) in Patients With High-Risk Ewing's Sarcoma, PNET or Rhabdomyosarcoma |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, busulfan, melphalan, thiotepa, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 16 |
| Start date | Mar 1, 1998 |
| Primary completion | Jan 1, 2002 |
| Completion | Jan 1, 2002 |
| First posted | Apr 27, 2004 |
| Last update posted | Sep 20, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: